HCA Healthcare Inc
XMUN:2BH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HCA Healthcare Inc
XMUN:2BH
|
US |
|
T
|
Tonnellerie Francois Freres SA
OTC:FRFTF
|
FR |
|
S
|
Singapore Telecommunications Ltd
F:SIT4
|
SG |
|
P
|
Pultegroup Inc
XMUN:PU7
|
US |
|
H
|
Healthequity Inc
SWB:2HE
|
US |
|
S
|
Southern Copper Corp
DUS:PCU
|
US |
|
E
|
Essential Utilities Inc
XBER:A2A
|
US |
|
S
|
Semirara Mining and Power Corporation
XPHS:SCC
|
PH |
|
V
|
Vertex Pharmaceuticals Inc
XMUN:VX1
|
US |
Wall St Price Targets
2BH Price Targets Summary
HCA Healthcare Inc
According to Wall Street analysts, the average 1-year price target for 2BH is 440.58 EUR with a low forecast of 316.64 EUR and a high forecast of 560.08 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2BH's stock price target?
Price Target
440.58
EUR
According to Wall Street analysts, the average 1-year price target for 2BH is 440.58 EUR with a low forecast of 316.64 EUR and a high forecast of 560.08 EUR.
What is the Revenue forecast for HCA Healthcare Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for HCA Healthcare Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 5%.
What is the Net Income forecast for HCA Healthcare Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 13%.
